Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Phillips 66 logo

Phillips 66 Cash Flow Statement

Operating, investing, and financing cash movements

Phillips 66 generated $2.5B in operating cash flow over the trailing twelve months. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$2.5BNet Cash From Investing (TTM)-$4.3BNet Cash From Financing (TTM)-$4.5BDepreciation And Amortization Cf (TTM)$3.0BNet Change In Cash (TTM)$3.7B
Latest FilingQ1 2026
Report Date2026-04-29
Market Cap$70.5B
P/E Ratio17.10
ROE14.78%

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other non-cash income (expense)-$147M$6M-$58M-$20M$141M$82M
Other non-cash income (expense)-$147M$6M-$58M-$20M$141M$82M
Change in accounts payable-$593M$384M$691M-$669M-$1.2B$3B
Change in inventories—$1.2B$393M$823M-$2.6B$1.7B
Change in receivables—-$901M$1.7B—$466M$2.5B
Deferred income taxes-$164M-$133M-$48M$14M$345M$67M
Depreciation and amortization$819M$791M$816M$826M$818M$558M
Unrealized Gain (Loss) on Equity Securities (FV-NI)$2M-$10M-$4M—-$2M-$9M
Other Non-Cash Income (Expense)-$147M$6M-$58M-$20M$141M$82M
Other Non-cash Income (Expense)-$147M$6M-$58M-$20M$141M$82M
Other Non-cash Income (Expense)-$147M$6M-$58M-$20M$141M$82M
Net cash from operating activities$1.2B$187M$845M$1.2B$2.8B-$2.3B
Net income$25M$526M$908M$167M$2.9B$219M
Other non-cash income (expense)-$147M$6M-$58M-$20M$141M$82M
Accretion Expense Including Asset Retirement Obligations$13M$12M$10M$12M$13M$12M
Asset write-downs$37M$26M$4M$951M$79M$8M
Gain (Loss) on Disposition of Other Assets$82M$1.1B$0$11M$2B$6M
Income Loss From Equity Method Investments Net Of Dividends Or Distributions—-$120M-$75M——$86M
Increase (Decrease) in Prepaid Expense and Other Assets-$102M$254M$172M$108M—$2.3B
Increase (Decrease) In Taxes And Other Accruals-$447M$111M$543M$57M—$470M
Other Noncash Income (Expense)-$147M$6M-$58M-$20M$141M$82M
Other Non-cash Income and Expense-$147M$6M-$58M-$20M$141M$82M
Other Non-Cash Adjustments-$147M$6M-$58M-$20M$141M$82M
Other Non-Cash Income and Expense-$147M$6M-$58M-$20M$141M$82M

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$58M$0$2.2B$0$1.3B$66M
Proceeds from Sales of Assets and Subsidiaries$176M$2B——$1.5B$7M
Capital Expenditures and Investments$506M$423M$587M$541M$682M$582M
Payment for (Proceeds from) Other Investing Activity—$45M-$57M-$28M—-$9M
Proceeds from disposition of property, plant and equipment/other$176M$2B——$1.5B$7M
Net cash from investing activities-$345M$1.6B-$2.7B-$487M-$467M-$606M
Dividend Received from Consumer Healthcare JV$19M$25M$18M$15M$32M$26M
Proceeds from sale of PPE and intangibles$176M$2B——$1.5B$7M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Proceeds from minority shareholders$0$0$106M$18M$8M$15M
Distributions to noncontrolling interests$24M$14M$81M$28M$41M$22M
Dividends paid$472M$469M$487M$484M$482M$509M
Proceeds from issuances of debt$1.1B$0$3.5B$2.5B$2.4B$9.6B
Other, net-$8M-$55M-$6M-$33M-$10M-$43M
Repayments of Debt and Lease Obligation$712M$1.3B$1.1B$1.6B$4.8B$2B
Net proceeds from sales of subsidiary shares$0$0$106M$18M$8M$15M
Payment of Deferred Purchase Consideration-$8M-$55M-$6M-$33M-$10M-$43M
Noncontrolling interest transactions and other-$8M-$55M-$6M-$33M-$10M-$43M
Proceeds from Minority Shareholders$0$0$106M$18M$8M$15M
Proceeds from Sale of Noncontrolling Interests$0$0$106M$18M$8M$15M
Net cash from financing activities-$724M-$2B——-$3.1B$6.9B
Noncontrolling Interests Activity and Other-$8M-$55M-$6M-$33M-$10M-$43M
Proceeds from Minority Shareholders$0$0$106M$18M$8M$15M
Proceeds from issuance of common stock$4M$23M$2M$68M$14M$84M
Repurchases of common stock$647M$247M$419M$267M$274M$269M
Proceeds from Minority Shareholders$0$0$106M$18M$8M$15M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$28M$22M$18M$3M$7M-$16M
Net increase (decrease) in cash—-$249M-$345M$806M-$834M$4B